LAKE ZURICH, Ill. - Fresenius Kabi, a health care company and part of the Fresenius Group, with a market capitalization of $447 million and a "FAIR" overall financial health rating according to ...

Fresenius Kabi is a global leader in supplying blood collection bags and devices, supporting blood banks and health care facilities worldwide. The company’s I.V. Generics and Fluids for infusion ...

Planegg-Martinsried, Germany – Formycon AG (FSE: FYB, Prime Standard, “Formycon”) and its commercialization partner Fresenius Kabi announce today that the U.S. Food and Drug Administration (FDA) ...

Fresenius Kabi's plant on Grand Island has a slogan: Saving lives one vial at a time. The plant, which employs about 800 people, makes sterile, injectable pharmaceuticals, used in doctors' offices ...

Fresenius Kabi, a producer of generic hospital medications, posted earnings before interest and taxes (EBIT) of 340 million euros ($356.8 million) for the quarter, up 21% year-on-year, largely due ...

With this approval, Fresenius Kabi Canada's immunology biosimilar portfolio is further expanding, offering more treatment options for patients with chronic autoimmune conditions Otulfi TM is ...

December 17, 2024--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, announced today that Epinephrine Injection, USP, is now available in the United States as the first generic ...

Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announces they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs).

Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies ...

Fresenius Kabi is a global leader in supplying blood collection bags and devices, supporting blood banks and health care facilities worldwide. The company's I.V. Generics and Fluids for infusion ...

Fresenius Kabi Philippines, Inc.—a global healthcare company that focuses on lifesaving medicines for infusion, transfusion, and clinical nutrition welcomed the first quarter of the year with ...